1. Corosolic acid enhances 5-fluorouracil-induced apoptosis against SNU-620 human gastric carcinoma cells by inhibition of mammalian target of rapamycin
    HYUN SU LEE et al, 2015, Molecular Medicine Reports CrossRef
  2. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells
    Dan Yang et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
  3. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines
    Julia Kneissl et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
  4. Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions
    Mark M. Moasser, 2022, Cancer Research CrossRef
  5. The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells
    Li-Fei Sun et al, 2020, Frontiers in Oncology CrossRef
  6. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes
    Laura Pentassuglia et al, 2016, American Journal of Physiology-Endocrinology and Metabolism CrossRef
  7. 5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells
    Kyuhwa Seo et al, 2017, Archives of Pharmacal Research CrossRef
  8. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
    Tasuku Matsuoka et al, 2014, Cancers CrossRef
  9. Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer
    Hidekazu Hirano et al, 2022, Scientific Reports CrossRef
  10. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
    Cheng-Ming Hsu et al, 2018, International Journal of Molecular Sciences CrossRef
  11. Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
    Ying-Chun Shen et al, 2014, Oncology CrossRef
  12. Anthocyanins Extracted from Oryza sativa L. Prevent Fluorouracil-Induced Nuclear Factor-κB Activation in Oral Mucositis: In Vitro and In Vivo Studies
    Salunya Tancharoen et al, 2018, International Journal of Molecular Sciences CrossRef
  13. NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
    Cheng-Ming Hsu et al, 2018, Cell Death Discovery CrossRef
  14. Association between the antioxidant properties of SESN proteins and anti-cancer therapies
    Joanna Kozak et al, 2023, Amino Acids CrossRef
  15. Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity
    Kensuke Shiraishi et al, 2013, Gastric Cancer CrossRef
  16. Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational study
    Xianchun Gao et al, 2023, International Journal of Surgery CrossRef
  17. Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells
    Bin Chen et al, 2015, PLOS ONE CrossRef
  18. Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus
    LING LIU et al, 2013, Experimental and Therapeutic Medicine CrossRef
  19. Targeting HER2 by Combination Therapies
    Ana Ruiz-Saenz et al, 2018, Journal of Clinical Oncology CrossRef
  20. Perspectives of the Stomach Cancer Treatment: The Introduction of Molecular Targeted Therapy and the Hope for Cure
    Dae Young Cheung et al, 2013, The Korean Journal of Gastroenterology CrossRef
  21. Two Dimensions in Targeting HER2
    Mark M. Moasser, 2014, Journal of Clinical Oncology CrossRef